Attention: Please take a moment to consider our terms and conditions before posting.
PSA testing matchday at The Valley on Saturday, April 11th 2026
shirty5
Posts: 19,381
PSA testing set for Preston North End matchday | Charlton Athletic Football Club
The club will host its annual PSA testing matchday at The Valley on Saturday, April 11th ahead of the men’s first-team's fixture against Preston North End.
Fans from both Charlton and Preston are eligible to book their slot, with 500 spaces available on the day. Bookings will be made available via the Barry Kilby Prostate Cancer Appeal website in due course.
The PSA test is a blood test that can help diagnose prostate problems, including prostate cancer - the most common cancer in men in the UK.
Men over 50, men with a family history of prostate cancer and black men are more at risk of prostate cancer.
The club’s annual PSA testing matchday was introduced at The Valley in 2018 by the club’s former Head of Player Care Tracey Leaburn, and more than 160 supporters have received flagged results following testing at The Valley, which they are advised to follow up on.
21
Comments
-
Brilliant that this is still happening.
Well done to all who continue to do this 👏🏼👏🏼👏🏼👏🏼5 -
Let's hope they don't move the kick off to an earlier one but that's as a dull a fixture in The Championship as you can get so we may survive the dreaded 12.301
-
The game at which we're presented with the Championship winners' trophy?oohaahmortimer said:Let's hope they don't move the kick off to an earlier one but that's as a dull a fixture in The Championship as you can get so we may survive the dreaded 12.301 -
Not just stealing our players and transfer targets, Preston are now stealing our PSA test slots
5 -
Great to see the Club continuing to do this and thanks to @Weegie Addick and CAST for picking up, after it looked like it wasn’t happening 👏🏻👏🏻7
-
Brilliant news that this is continuing. Thats me in the picture having my test done earlier this year. Defo got my best side👍2
-
Thanks, Tel. Think a few people contacted the club, so credit where it’s due for them now ensuring it is firmly in the diary.TelMc32 said:Great to see the Club continuing to do this and thanks to @Weegie Addick and CAST for picking up, after it looked like it wasn’t happening 👏🏻👏🏻2 -
Just an update - when I have been looking on the Charity Webpage to book, the event doesn't show yet. Just signed in on the same page with my account details and the event is there and available to book which I have done.
Edit - Henry has kindly added the link below and now on their bookings page too.0 -
https://news.sky.com/story/national-prostate-cancer-screening-not-recommended-on-nhs-13476471
After being advised for a number of years now that us men of a certain age should get a PSA test done to detect potential prostate problems, apparently the National Screening Committee aren't recommending it, even for higher risk groups.
It's hard enough to convince men to visit a doctor's at the best (or worst) of times, but this feels like a missed opportunity to detect the most common cancer in men at an early stage.5 -
Sponsored links:
-
Yep they reckon currently testing for men except those known to have the BRCA gene mutation is an unnecessary risk.addix said:https://news.sky.com/story/national-prostate-cancer-screening-not-recommended-on-nhs-13476471
After being advised for a number of years now that us men of a certain age should get a PSA test done to detect potential prostate problems, apparently the National Screening Committee aren't recommending it, even for higher risk groups.
It's hard enough to convince men to visit a doctor's at the best (or worst) of times, but this feels like a missed opportunity to detect the most common cancer in men at an early stage.0 -
The problem about the gene mutation is the only way to suspect you have it, is you need to know the history of breast cancer in your family. Hardly any men are that aware of the history of the illness of the women of the family before they were born.2
-
Booked, thanks to all involved.0
-
You'd at least think it make sense to test those with a family history of prostate cancer, even if they don't have the BRCA mutation.msomerton said:The problem about the gene mutation is the only way to suspect you have it, is you need to know the history of breast cancer in your family. Hardly any men are that aware of the history of the illness of the women of the family before they were born.0 -
Not recomended.aliwibble said:
You'd at least think it make sense to test those with a family history of prostate cancer, even if they don't have the BRCA mutation.msomerton said:The problem about the gene mutation is the only way to suspect you have it, is you need to know the history of breast cancer in your family. Hardly any men are that aware of the history of the illness of the women of the family before they were born.0 -
watching the interview it appears they’re saying people are having ops that affect them when the cancer is minimal and would just not progress in to anything anyway , fuck knows , let the experts work it out , sounds like pros and cons and you have to hopefully have the right doctor who would know how to approach it all if the gene exists .
I had a full health check recently (privately) and my GP as part of it said have this Stockholm test , I think it was £250 , here’s what chat gpt or whatever it is came up on my search . The cost here is a massive issue and over time this will hopefully come down .
Thankfully I was a low risk result.The Stockholm3 test is an advanced blood test for prostate cancer risk assessment that combines multiple protein and genetic markers with clinical data to provide a more accurate risk score than the traditional PSA test. It helps identify men with a high risk of aggressive prostate cancer, even those with a low PSA level, leading to a more personalized and resource-efficient approach to follow-up, potentially reducing unnecessary biopsies.How it works- Combines multiple factors: The test analyzes more than just Prostate-Specific Antigen (PSA). It measures the levels of five protein markers and incorporates the presence of genetic markers (SNPs).
- Uses an algorithm: These different data points are fed into a proprietary algorithm that calculates a personalized risk score for developing clinically significant prostate cancer.
- Identifies high-risk individuals: A key advantage is its ability to find aggressive prostate cancers in men with normal PSA levels, which the traditional PSA test might miss.
What the results mean- Low Risk (e.g., green light): Typically indicates a low probability of aggressive cancer, and a repeat test may be recommended in several years.
- Normal Risk (e.g., yellow light): May warrant a repeat test in one to two years.
- High Risk (e.g., red light): Usually prompts a referral to a urologist for further investigation, such as an MRI or biopsy.
Benefits- Higher accuracy: Offers a more precise prediction of risk compared to PSA alone.
- Reduces unnecessary procedures: By more accurately identifying who is at high risk, it helps reduce the number of men who undergo unnecessary biopsies.
- Supports early detection: Helps find aggressive prostate cancers at an earlier, more treatable stage.
1
